nelfinavir has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badley, AD; Bennett, SA; Bren, GD; Brenner, C; Deniaud, A; Dong, L; Douen, A; Hardin, H; Hou, ST; Jiang, SX; Kroemer, G; Kroemer, RT; Lallier, J; Lebras, M; Lynch, DH; Moffat, TC; Morin, MY; Phenix, BN; Sim, VL; Tarze, A; van Heeswijk, RP; Weaver, JG; Wettstein, P; Zurakowski, B | 1 |
1 other study(ies) available for nelfinavir and Shock, Septic
Article | Year |
---|---|
Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.
Topics: Animals; Antibodies; Apoptosis; Disease Models, Animal; Female; Hepatitis; HIV Protease Inhibitors; Humans; Jurkat Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondrial ADP, ATP Translocases; Models, Molecular; Nelfinavir; Ritonavir; Shock, Septic; Signal Transduction; Stroke | 2005 |